TY - JOUR
T1 - Evidence-based efforts to prevent HIV infection
T2 - An overview of current status and future challenges
AU - Holtgrave, David
N1 - Funding Information:
With regard to structural interventions, other programs, including federal programs, may play a role in preventing HIV infection. Programs established by the Health Resources and Services Administration, the CDC, and the Centers for Medicare and Medicaid Services are discussed elsewhere in this supplement. The Housing Opportunities for Persons with HIV/ AIDS program is funded by the Department of Housing and Urban Development. Published studies have shown that there is a strong relationship between housing status and risk behavior as well as detectability of viral load [22].
Funding Information:
The “Opportunities for Improving HIV Diagnosis, Prevention & Access to Care in the U.S.” conference was sponsored by the American Academy of HIV Medicine, amfAR, the Centers for Disease Control and Prevention, the Forum for Collaborative HIV Research, the HIV Medicine Association of the Infectious Diseases Society of America, and the National Institute of Allergy and Infectious Diseases. Funding for the conference was supplied through an unrestricted educational grant from Gilead Sciences, amfAR, GlaxoSmithKline, Pfizer, Abbott Virology, OraSure Technologies, Roche Diagnostics, and Trinity Biotech.
PY - 2007/12/15
Y1 - 2007/12/15
N2 - Since the early 1990s, the incidence of human immunodeficiency virus (HIV) infection in the United States has been ∼40,000 cases per year. Because this rate has not decreased substantially in >15 years, the efficacy and cost-effectiveness of programs to prevent HIV infection have come under intensifying examination. In this article, several issues are addressed, including the efficacy of HIV prevention strategies at the national level in the United States, the status of the goals from the current (albeit expired) national HIV prevention plan, the role of opt-out HIV testing in a new comprehensive national HIV prevention plan, and a review of evidence-based prevention strategies that should be emphasized in a new plan.
AB - Since the early 1990s, the incidence of human immunodeficiency virus (HIV) infection in the United States has been ∼40,000 cases per year. Because this rate has not decreased substantially in >15 years, the efficacy and cost-effectiveness of programs to prevent HIV infection have come under intensifying examination. In this article, several issues are addressed, including the efficacy of HIV prevention strategies at the national level in the United States, the status of the goals from the current (albeit expired) national HIV prevention plan, the role of opt-out HIV testing in a new comprehensive national HIV prevention plan, and a review of evidence-based prevention strategies that should be emphasized in a new plan.
UR - http://www.scopus.com/inward/record.url?scp=40949154387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40949154387&partnerID=8YFLogxK
U2 - 10.1086/522553
DO - 10.1086/522553
M3 - Review article
C2 - 18190302
AN - SCOPUS:40949154387
SN - 1058-4838
VL - 45
SP - S293-S299
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - SUPPL. 4
ER -